CD8A and neoplasm: CD8+ T lymphocytes remain the crucial effectors of immune cells and, through an interaction between their T cell receptor (TCR) and the major histocompatibility complex (MHC-I) antigen on tumor cells, they excrete granzyme B or perforin to exterminate HCC cells [99,102].